<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE311nnn/GSE311971/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Genomics</omics_type><species>Homo sapiens</species><gds_type>Genome binding/occupancy profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311971</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Regulation of lineage reprogramming by dynamic chromatin SUMOylation (ChIP-seq)</name><description>SUMOylation has emerged as a key regulator of chromatin and transcription, yet its contribution to lineage reprogramming remains unclear. To explore how chromatin SUMOylation influences cellular plasticity, we studied CEBPA-driven lineage reprogramming of human leukemic B-cells into macrophage-like cells. By integrating ChIP-seq, ATAC-seq, RNA-seq and chromatin-directed proteomics, we mapped the chromatin landscape and transcriptomic changes during early reprogramming. Lineage conversion triggered a dynamic rise in SUMO2/3 chromatin occupancy at CEBPA-bound sites, revealing a coordinated regulatory mechanism. Proteomic profiling of SUMO2/3- and CEBPA-associated chromatin uncovered extensive convergence and enrichment of differentiation-related transcription factors, chromatin remodelers and coregulators. Among these, NCOA3 displayed markedly increased SUMO2/3 association upon lineage conversion. NCOA3 co-occupied CEBPA- and SUMO2/3-bound chromatin regions, implying a SUMOylation-supported coregulatory role in lineage reprogramming. Pharmacological inhibition of SUMOylation using ML-792 (SUMOi) selectively enhanced CEBPA chromatin occupancy and chromatin accessibility, altered the CEBPA association of proteins, and modified NCOA3 binding dynamics. SUMOi also reshaped gene expression, promoting loss of B-cell identity and activation of macrophage-associated programs, including lipid metabolism. Collectively, our findings highlight chromatin SUMOylation as a dynamic and context-dependent modifier that fine-tunes lineage transitions, with implications for chromatin biology and therapeutic modulation of cell identity.</description><dates><publication>2026/05/27</publication></dates><accession>GSE311971</accession><cross_references><GSM>GSM9335403</GSM><GSM>GSM9335404</GSM><GSM>GSM9335401</GSM><GSM>GSM9335423</GSM><GSM>GSM9335424</GSM><GSM>GSM9335402</GSM><GSM>GSM9335407</GSM><GSM>GSM9335408</GSM><GSM>GSM9335405</GSM><GSM>GSM9335406</GSM><GSM>GSM9335384</GSM><GSM>GSM9335385</GSM><GSM>GSM9335421</GSM><GSM>GSM9335388</GSM><GSM>GSM9335389</GSM><GSM>GSM9335422</GSM><GSM>GSM9335400</GSM><GSM>GSM9335386</GSM><GSM>GSM9335387</GSM><GSM>GSM9335420</GSM><GSM>GSM9335414</GSM><GSM>GSM9335415</GSM><GSM>GSM9335412</GSM><GSM>GSM9335413</GSM><GSM>GSM9335418</GSM><GSM>GSM9335419</GSM><GSM>GSM9335416</GSM><GSM>GSM9335417</GSM><GSM>GSM9335395</GSM><GSM>GSM9335396</GSM><GSM>GSM9335393</GSM><GSM>GSM9335394</GSM><GSM>GSM9335410</GSM><GSM>GSM9335399</GSM><GSM>GSM9335411</GSM><GSM>GSM9335397</GSM><GSM>GSM9335398</GSM><GSM>GSM9335391</GSM><GSM>GSM9335392</GSM><GSM>GSM9335390</GSM><GSM>GSM9335409</GSM><GPL>11154</GPL><GSE>311971</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>